News | December 10, 2013

Surgeon Astronaut Shares Experience of How Microgravity Effects the Body

December 10, 2013 — The human body begins to adapt to microgravity of low Earth orbit shortly after launch, according to surgeon astronaut Lee Morin, M.D., Ph.D., and astronaut mission specialist, NASA Johnson Space Center, Houston. Morin visited the International Space Station in 2002 as part of the STS-110 Atlantis space shuttle crew.
 
"Evolution has not prepared the human body for the space environment. However, the human body does successfully adapt to space,” said Morin at the 40th Annual VEITHsymposium. “These changes begin immediately upon exposure to microgravity, although understanding is confounded by the stresses during launch from the Earth's surface into low Earth orbit. The engineering and physics constraints of rocket science bracket the launch duration to furious eight or nine minutes. Immediately post-insertion, adaptation begins.”
 
Morin shared his experience in space, along with the effects of microgravity on the body's systems. According to Morin, fluid shifts immediately from the lower extremities to the upper part of the body and superficial veins in the neck become engorged. Within the first 15 minutes, up to two-thirds of astronauts suffer from motion sickness that can last up to seven days.
 
The cardiovascular system experiences a number of changes, including increased cardiac output; a 10 to 15 percent plasma volume loss begins immediately along with a 10 percent reduction in erythrocyte mass. 
 
"Fortunately, cardiovascular changes of space do not threaten survival,” said Morin. “There is no increase of arrhythmias in space.”
 
Changes to the musculoskeletal system develop with medium to long-term microgravity exposures. Skeletal muscle atrophies and strength is lost. Bone mineral density is also affected with a loss rate of about 1.5 percent per month from the weight bearing bones. 
 
"Over the past decade we have learned to control these losses with heavy resistive exercise on a daily basis," said Morin.
 
Radiation exposure is the most significant health threat in microgravity. Spacecraft can only be partially shielded from radiation. 
 
"Crew can sense radiation, they often report light flashes within their eyes, usually when eyes are closed pre-sleep," said Morin. 
 
The primary radiation risk to the crew is increased lifetime cancer mortality.
 
For more information: www.veithpress.org, www.veithsymposium.org

Related Content

News | Cardiovascular Clinical Studies

April 24, 2024 —Hello Heart, a digital leader in preventive heart health, today announced results from its latest study ...

Home April 24, 2024
Home
News | Cardiovascular Clinical Studies

April 22, 2024 — Corvia Medical, Inc, a company dedicated to transforming the treatment of heart failure, welcomes the ...

Home April 22, 2024
Home
News | Cardiovascular Clinical Studies

April 16, 2024 — CVRx, Inc., a commercial-stage medical device company, announced today the availability of additional ...

Home April 16, 2024
Home
News | Cardiovascular Clinical Studies

April 11, 2024 — Transcatheter aortic valve replacement (TAVR) was found to bring no increased risks and was associated ...

Home April 11, 2024
Home
News | Cardiovascular Clinical Studies

April 11, 2024 — People with a buildup of fatty atherosclerotic plaque in the heart’s arteries considered at risk of ...

Home April 11, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Patients who took an angiotensin-converting enzyme (ACE) inhibitor while undergoing cancer treatment ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — One of the first studies to attempt to treat early-stage heart failure in patients with Type 2 diabetes ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — The investigational drug ninerafaxstat showed a good tolerability and safety profile, along with ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Administering tranexamic acid (TxA), a drug used to reduce bleeding during heart surgery, topically ...

Home April 09, 2024
Home
News | Cardiovascular Clinical Studies

April 9, 2024 — Using a web application to qualify individuals for treatment with a nonprescription statin closely ...

Home April 09, 2024
Home
Subscribe Now